Evidence map›Paper›PMID 40305234›Full record

ArticleBiomolecules2025

Exploring the Association Between

Victor M Mora, Emilio Rodrigo, David Iturbe-Fernández, Sheila Izquierdo, Sandra Tello, Adalberto Benito-Hernández, Maria Mar García-Saiz, David San Segundo, María Victoria Francia, Jose M Cifrián

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomolecules, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Victor M MoraImmunopathology Group, Respiratory Department, Marqués de Valdecilla University Hospital-IDIVAL, University of Cantabria, 39005 Santander, Spain.ORCID 0000-0002-8161-0462
Emilio RodrigoImmunopathology Group, Nephrology Department, Marqués de Valdecilla University Hospital-IDIVAL, University of Cantabria, 39005 Santander, Spain.ORCID 0000-0002-2845-5272
David Iturbe-FernándezImmunopathology Group, Respiratory Department, Marqués de Valdecilla University Hospital-IDIVAL, University of Cantabria, 39005 Santander, Spain.ORCID 0000-0002-5241-266X
Sheila IzquierdoImmunopathology Group, Respiratory Department, Marqués de Valdecilla University Hospital-IDIVAL, University of Cantabria, 39005 Santander, Spain.
Sandra TelloImmunopathology Group, Respiratory Department, Marqués de Valdecilla University Hospital-IDIVAL, University of Cantabria, 39005 Santander, Spain.
Adalberto Benito-HernándezImmunopathology Group, Nephrology Department, Marqués de Valdecilla University Hospital-IDIVAL, University of Cantabria, 39005 Santander, Spain.
Maria Mar García-SaizClinical Pharmacology Department, Marqués de Valdecilla University Hospital-IDIVAL, 39005 Santander, Spain.ORCID 0000-0001-5291-3109
David San SegundoImmunopathology Group, Immunology Department, Marqués de Valdecilla University Hospital-IDIVAL, University of Cantabria, 39005 Santander, Spain.ORCID 0000-0001-5745-9072
María Victoria FranciaInfectious Diseases and Clinical Microbiology Group, Marqués de Valdecilla University Hospital-IDIVAL, University of Cantabria, 39005 Santander, Spain.ORCID 0000-0003-0209-0145
Jose M CifriánImmunopathology Group, Respiratory Department, Marqués de Valdecilla University Hospital-IDIVAL, University of Cantabria, 39005 Santander, Spain.ORCID 0000-0003-3682-0142

Funding

Instituto de Salud Carlos III PI20/01710, RD21/0005/0010, RD24/0004/0019
6 · The paper itself

Abstract

To improve lung transplant recipient (LungTx) outcome, it would be of great interest to measure the net state of immunosuppression to avoid both infection and rejection. Measurement of

Indexed as

Immunosuppressive AgentsLung TransplantationTorque teno virusViral LoadAdultFemaleGraft RejectionHumansMaleMiddle AgedMycophenolic AcidProspective StudiesTacrolimusImmunosuppressive AgentsMycophenolic AcidTacrolimusacute rejectionimmune responseimmunosuppressive drugsinfectionlung transplantationmonitoringmycophenolic acidtacrolimusTorquetenovirus

Identifiers

PMID40305234
PMCPMC12024801

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.